United States

Aralez Pharmaceuticals Inc (ARZ.TO)

ARZ.TO on Toronto Stock Exchange

3:57pm EDT
Change (% chg)

$-0.09 (-1.40%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Aralez Q2 GAAP loss per share $0.27
Tuesday, 9 Aug 2016 08:00am EDT 

Aralez Pharmaceuticals Inc : Aralez reports second quarter 2016 financial results . Q2 revenue $12.6 million versus $5.2 million . Q2 GAAP loss per share $0.27 .Q2 earnings per share view $-0.22, revenue view $11.9 million -- Thomson Reuters I/B/E/S.  Full Article

Aralez posts Q1 loss of $0.73/share
Tuesday, 10 May 2016 07:29am EDT 

Aralez Pharmaceuticals Inc : Aralez reports first quarter 2016 financial results . Qtrly GAAP loss per share $0.73 .Total net revenues for three months ended March 31, 2016 were about $8.1 million compared to $4.4 million.  Full Article

Aralez Pharmaceuticals receives Health Canada approval For BLEXTEN
Monday, 25 Apr 2016 07:00am EDT 

Aralez Pharmaceuticals:Says Health Canada approval of BLEXTEN for treatment of symptoms of seasonal allergic rhinitis and chronic spontaneous urticaria.BLEXTEN will be distributed in Canada by Tribute Pharmaceuticals Canada Inc, also a subsidiary of Company.  Full Article


U.S. approves Aralez pill for heart patients; stock jumps

The U.S. Food and Drug Administration on Thursday approved a pill that combines aspirin and the acid-fighting drug omeprazole to guard against gastric ulcers in patients who require daily aspirin.

No consensus analysis data available.